ストックスクリーナーアプリを入手
5.975
1.57%
-0.095
前日終値:
$6.07
開ける：
$6.14
24時間の取引高:
77,103
Relative Volume:
1.01
時価総額：
$179.73M
収益：
-
当期純損益:
$-13.08M
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-0.42%
1か月 パフォーマンス:
+49.75%
6か月 パフォーマンス:
+4.28%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$5.6754
$6.275
1週間の範囲:
$5.6754
$6.30
52週間の値動き範囲:
$3.11
$20.72
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
名前
Telomir Pharmaceuticals Inc
セクター
電話
(813) 864-2562
住所
900 WEST PLATT STREET, SUITE 200, TAMPA
Telomir Pharmaceuticals Inc (TELO) 最新ニュース
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Sees Significant Increase in Short Interest - MarketBeat
Telomir Pharmaceuticals (NASDAQ:TELO) Trading Up 2.2% - Defense World
Telomir Pharmaceuticals (NASDAQ:TELO) Trading 2.2% Higher - MarketBeat
What Is Going On With AST SpaceMobile Stock? - Barchart
Experience The Future Of Smart Living With Hisense At IFA 2024 - Barchart
Boeing's troubled space capsule ends mission with a landing in the New Mexico desert, leaving two astronauts in orbit - Barchart
Stakeholder In Trump's Truth Social Parent Company Wins Court Ruling Over Share Transfer - Barchart
Is RTX Corporation Stock Outperforming The S&P 500? - Barchart
US Hiring Rebounds Slightly And Unemployment Rate Dips In Sign Of Still-Slowing Job Market - Barchart
Telegram CEO Defends Himself Against French Charges In First Public Comments - Barchart
New Mexico attorney general sues company behind Snapchat alleging child sexual extortion on the site - Barchart
IGM FINANCIAL INC. ANNOUNCES AUGUST 2024 ASSETS UNDER MANAGEMENT & ADVISEMENT AND NET FLOWS - Barchart
Media AdvisoryPrime Minister's Itinerary For Friday, September 6, 2024 - Barchart
ALIMENTATION COUCHE-TARD INC. ANNOUNCES ELECTION OF DIRECTORS - Barchart
With Musk's X Banned In Brazil, Its Users Carve Out New Digital Homes - Barchart
Telomir Pharmaceuticals’ Age Reversal Drug Shows Promise in Canine Study - Vancity Buzz
Obesity Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Novo Nordisk, Boehringer Ingelheim, Pfizer, BioAge Labs, Aphaia Pharma, Neothetics, NovMetaPharma, Carmot - Barchart
Applications For US Jobless Benefits Fall To 2-Month Low As Layoffs Remain At Healthy Levels - Barchart
WCAS Completes Acquisition Of EquiLend - Barchart
Telomir Pharmaceuticals (NASDAQ: TELO) Featured In Local ABC Exclusive Showing Positive Outcomes Of Proposed Age Reversal Pill In Dogs | FinancialContent Business Page - Financial Content
Soft Tissue Sarcoma Market is expected to grow at a significant CAGR, DelveInsight | Advenchen Laboratories, Philogen, Gradalis, Epizyme, Chugai Pharma France, CytRx, Taiho Pharmaceuticals, KaryoPharm - Barchart
FuelCell Energy: Fiscal Q3 Earnings Snapshot - Barchart
Telomir names Dr. Itzchak Angel as Chief Scientific Advisor - Investing.com
Telomir names Dr. Itzchak Angel as Chief Scientific Advisor - Investing.com India
Unusual Activity In Block Inc. OptionsHighlights SQ Stock's Value - Barchart
Telomir names Dr. Itzchak Angel as Chief Scientific Advisor By Investing.com - Investing.com Canada
Protecting Homeowners From Unnecessary Financial Stress - Barchart
US Job Openings Fall As Demand For Workers Cools - Barchart
Amyotrophic Lateral Sclerosis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Amylyx Pharma, Ionis Pharma, Annexon, Inc., UniQure Biopharma, Sangamo Therapeutics - Barchart
Litecoin May Have Bottomed - Barchart
Telomir names Dr. Itzchak Angel as Chief Scientific Advisor By Investing.com - Investing.com UK
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications - Milton Daily Standard
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications - AccessWire
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications - StockTitan
Telomir Pharmaceuticals recruits ex-Synthelabo executive - Investing.com
Eaton Corporation Stock: Is ETN Outperforming The Industrials Sector? - Barchart
Is Union Pacific Corporation Stock Outperforming The Dow? - Barchart
The growth track for Telomir Pharmaceuticals Inc (TELO) has changed recently - SETE News
Quarterly Metrics: Quick and Current Ratios for Telomir Pharmaceuticals Inc (TELO) - The Dwinnex
Regeneron Pharmaceuticals Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart
Mira Pharmaceuticals (NASDAQ:MIRA) Stock Quotes, Forecast and News Summary - Benzinga
Telomir Pharmaceuticals (NASDAQ:TELO) Stock Price Up 3.2% - MarketBeat
Telomir Pharmaceuticals (NASDAQ:TELO) Trading Up 3.2% - Defense World
Telomir-1 shows promise in aging dogs, eyes human trials - Investing.com
TELO Stock: Exploring Telomir Pharmaceuticals Inc’s Growth - The InvestChronicle
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs - Milton Daily Standard
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs - Brazosport Facts
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs - AccessWire
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs - StockTitan
Telomir Pharmaceuticals (NASDAQ:TELO) Stock Quotes, Forecast and News Summary - Benzinga
ABC7 Exclusive: New study reveals promising results for age reversal pill on dogs - WWSB
Telomir Pharmaceuticals Inc (TELO) 財務データ
収益
当期純利益
現金流量
EPS
1.19%
1.65%
大文字化:
|
ボリューム (24 時間):